1Wells PS, Holbrook AM, Crowther NR, et al. The inter action of warfarin with drugs and food: a critical review of the literature [J]. Ann Intern Med, 1994, 121:676.
同被引文献22
1Holbrook AM, Pereira JA, Labiris R, et al. Systematic overview ofwarfarin and its drug and food interactions [ J ]. Arch Intern Med, 2005,165 : 1095 - 1106.
2Marie A, Jolene R, Ilze Stuffs Hallman. Warfarin drug interactions: strategies to minimize adverse drug events[ J]. J Nurse Pract, 2011, 7:506 -512.
3Kearon C, Kahn SR, Agnelli G, et al. Antithrombotic therapy for venous thromboernbolie disease: American College of Chest Physi- cians Evidence - Based Clinical Practice Guidelines ( 8th Edition ) [J]. Chest, 2008,133:454S -545S.
4Dowd MB, Vavra KA, Witt DM, et al. Empiric warfarindose adjust- ment with prednisone therapy. A randomized, controlled trial [ J ]. J Thromb Thrombolysis , 2011,31:472.
5Malhi H, Atac B, Daly AK, et al. Warfarin and celecoxib interac- tion in the setting of cytochrome P450(CYP2C9) polymorphism with bleeding complication[ J]. Postgrad Med J, 2004,80 : 107 - 109.
6ASCAH K J, ROCK G A, WELLS P S. Interaction between fenofibrate and warfarin [J]. Ann Pharmacother, 1998, 32(7/8): 765-768.
7WESTERGREN T, JOHANSSON P, MOLDEN E. Probable warfarin-simvastatin interaction [J]. Ann Pharmacother, 2007, 41(7): 1292-1295.
8KIM K Y, MANCANO M A. Fenofibrate protentiates warfarin effects. Ann Pharmacother, 2003, 37(2): 212-215.
9MILLER D B, SPENCE J D. Clinical pharmacokinetics of fibric acid derivatives(fibrates) [J]. Clin Pharmacokinet, 1998, 34(2): 155-162.
10NARANJO C A, BUSTO U, SELLERS E M, et al. A method for estimating the probability of adverse drug reaction [J]. Clin Pharmacol Ther, 1981, 30(2): 239-245.
